US switch to recombinant shingles vaccine linked to lower cardiovascular risk
TL;DR
A Nature Medicine study using US electronic health record data finds that older adults vaccinated predominantly with the recombinant shingles vaccine exhibit a lower cardiovascular disease burden over seven years, with reduced risks for heart failure and ischemic heart disease, and a modest, sex-specific reduction in ischemic stroke; though associations persist across analyses, causality cannot be established and effects may wane over time.
Topics:healthmedical-research#cardiovascular-disease#medical-research#nature-medicine#observational-study#recombinant-vaccine#shingles-vaccine
- The US switch in shingles vaccines revealed an unexpected heart health pattern News-Medical
- Common vaccine linked to 24% lower dementia risk in older adults Fox News
- Current shingles vaccine linked to lower risk of coronary heart disease, stroke and heart failure Medical Xpress
- Shingles vaccine may lower risk of stroke and heart failure New Scientist
- Does the shingles vaccine cut heart-disease risk? Mounting evidence suggests a link Nature
Want the full story? Read the original reporting
Read on News-Medical